Reversible congestive heart failure caused by myocardial hibernation

Texas Heart Institute Journal

Volumn 26, Issue 1, 1999, Pages 19-27

  Wilson, James M ^a,b  

^a TEXAS HEART INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Angioplasty; Coronary disease; Deoxyglucose diagnostic use; Dobutamine diagnostic use; Fluorine radioisotopes diagnostic use; Myocardial hibernation; Myocardial ischemia; Myocardial revascularization; Myocardial stunning; Technetium Tc 99m sestamibi diagnostic use; Thallium radioisotopes diagnostic use; Ventricular dysfunction left etiology

Indexed keywords

CYCLIC GMP; NITRIC OXIDE;

ADULT; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; MALE; MYOCARDIAL HIBERNATION; PATHOPHYSIOLOGY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DIAGNOSTIC IMAGING; ENERGY METABOLISM; HEART FAILURE, CONGESTIVE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL STUNNING; PROGNOSIS; STENTS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0032914489     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Bruschke AV, Proudfit WL, Sones FM Jr. Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. I. Arteriographic correlations. Circulation 1973;47:1147-53.
2. Bruschke AV, Proudfit WL, Sones FM Jr. Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. II. Ventriculographic and other correlations. Circulation 1973;47:1154-63.
3. Hall RJ, Mathur VS, Garcia E, de Castro CM. The prolongation of life by coronary bypass surgery. In: Hurst JW, editor. Update II: the heart. Bypass surgery for obstructive coronary disease. New York: McGraw-Hill, 1980:175-204.
4. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med 1984;311:1333-9.
5. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990;82:1629-46.
6. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988;319:332-7.
7. Bourassa MG, Lesperance J, Campeau L, Saltiel J. Fate of left ventricular contraction following aortocoronary venous grafts. Early and late postoperative modifications. Circulation 1972;46:724-50.
8. Chatterjee K, Swan HJ, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation 1973;47:276-86.
9. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72(6 Pt 2):V123-35.
10. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998;339:173-81.
11. Camici PG, Wijns W, Borgers M, De Silva R, Ferrari R, Knuuti J, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997;96:3205-14.
12. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
13. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 1995;76:479-88.
14. Chen C, Gillam L, Chen L, Knibb D, Knight D, Waters D. Temporal hierarchy in functional and ultrastructural recoveries between short-term and chronic hibernating myocardium after reperfusion [abstract]. Circulation 1995;92(Suppl I):1-552.
15. Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920-31.
16. Schwarz ER, Schoendube FA, Kostin S, Schmiedtke N, Schulz G, Buell U, et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol 1998;31: 1018-26.
17. Ausma J, Cleutjens J, Thone F, Flameng W, Ramaekers F, Borgers M. Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem 1995;147:35-42.
18. Hennessy T, Diamond P, Holligan B, O'Keane C, Hurley J, Codd M, et al. Correlation of myocardial histologic changes in hibernating myocardium with dobutamine stress echocardiographic findings. Am Heart J 1998;135(6 Pt 1):952-9.
19. Kaprielian RR, Gunning M, Dupont E, Sheppard MN, Rothery SM, Underwood R. et al. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 1998;97:651-60.
20. Schwarz ER, Schaper J, vom Dahl J, Altehoefer C, Grohmann B, Schoendube F, et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 1996; 27:1577-85.
21. Ausma J, Furst D, Thone F, Shivalkar B, Flameng W, Weber K, et al. Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation. J Mol Cell Cardiol 1995;27:1203-12.
22. Ausma J, Schaart G. Thoné F, Shivalkar B, Flameng W, Depré C, et al. Chronic ischemic viable myocardium in man: aspects of dedifferentiation. Cardiovasc Pathol 1995;4:29-37.
23. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.
24. Go RT, MacIntyre WJ, Cook SA, Neumann DR, Brunken RC, Saha GB, et al. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorode-oxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction. J Nucl Cardiol 1996;3:96-104.
25. Gunning MG, Chua TP, Harrington D, Knight CJ, Burman E, Pennell DJ, et al. Hibernating myocardium: clinical and functional response to revascularisation. Eur J Cardiothorac Surg 1997;11:1105-12.
26. Di Carli MF, Davidson M, Little R. Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
27. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
28. Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 1992;69:854-9.
29. Eitzman D, al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
30. Anselmi M, Golia G, Cicoira M, Tinto M, Nitti MT, Trappolin R, et al. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol 1998;81(12A):21G-28G.
31. Cornel JH, Bax JJ, Elhendy A, Maat AP, Kimman GJ, Geleijnse ML, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998;31:1002-10.
32. Scognamiglio R, Marin M, Miorelli M, Palisi M, Fasoli G, Dalla Volta S. Postextrasystolic potentiation echocardiography in predicting reversible myocardial dysfunction by surgical coronary revascularization. Am J Cardiol 1998;81(12A):36G-40G.
33. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
34. Nagueh SF, Vaduganathan P, Ali N, Blaustein A, Verani MS, Winters WL Jr, et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997;29: 985-93.
35. Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-8.
36. Helfant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS. Nitroglycerin to unmask reversible asynergy. Correlation with post coronary bypass ventriculography. Circulation 1974;50:108-13.
37. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23: 617-26.
38. Arnese M, Cornel JH, Salustri A, Maat A, Elhendy A, Reijs AE, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995; 91:2748-52.
39. Vanoverschelde JL, D'Hondt AM, Marwick T, Gerber BL, De Kock M, Dion R, et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996: 28:432-42.
40. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
41. Zimmermann R, Mall G, Rauch B, Zimmer G, Gabel M, Zehelein J, et al. Residual 201Tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological study. Circulation 1995;91:1016-21.
42. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
43. Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994;89:2552-61.
44. Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Reijs AE, et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorode-oxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558-64.
45. deFilippi CR, Willett DL, Irani WN, Eichhorn EJ, Velasco CE, Grayburn PA. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995;92:2863-8.
46. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutamine-gradientecho magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-15.
47. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
48. Bisi G, Sciagra R, Santoro GM, Rossi V, Fazzini PF. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995;36:1994-2000.
49. Sciagra R, Bisi G, Santoro GM, Zerauschek F, Sestini S, Pedenovi P, et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997;30:384-91.
50. Kostopoulos KG, Kranidis AI, Bouki KP, Antonellis JP, Kappos KG, Rodogianni FE, et al. Detection of myocardial viability in the prediction of improvement in left ventricular function after successful coronary revascularization by using the dobutamine stress echocardiography and quantitative SPECT rest-redistribution-reinjection 201Tl imaging after dipyridamole infusion. Angiology 1996;47:1039-46.
51. Ma L, Chen L, Gillam L, Waters DD, Chen C. Nitroglycerin enhances the ability of dobutamine stress echocardiography to detect hibernating myocardium. Circulation 1997;96:3992-4001.
52. Gerber B, Laycock SK, Melin JA, Flameng W, Vanoverschelde JL. Perfusion-contraction matching, inotropic reserve and vasodilatory capacity in a canine model of dysfunctional collateral-dependent myocardium [abstract]. Circulation 1995;92(Suppl I):1-314.
53. Dakik HA, Howell JF, Lawrie GM, Espada R, Weilbaecher DG, He ZX, et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96:2892-8.
54. Matsunari I, Boning G, Ziegler SI, Nekolla SG, Stollfuss JC, Kosa I, et al. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-flourodeoxyglucose. J Am Coll Cardiol 1998;32:927-35.
55. McNulty PH, Sinusas AJ, Shi CQ, Dione D, Young LH, Cline GC, et al. Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia. J Clin Invest 1996;98:62-9.
56. Cohen M, Charney R. Hershman R, Fuster V, Gorlin R. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol. 1988;12: 1193-8.
57. Meluzin J, Cerny J, Frelich M, Stetka F, Spinarova L, Popelova J, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 1998;32:912-20.
58. Afridi I, Grayburn PA, Parza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998;32:921-6.